Quantify’s Emma Söreskog, Ingrid Lindberg, Oskar Ström and Fredrik Borgström have co-authored two recently published papers on cost-effectiveness modelling in osteoporosis. One of the papers presents a new framework for modelling osteoporosis treatments and the other presents a cost-effectiveness analysis of romosozumab in Sweden.